Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Carr's Group in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 129.25.
Current Consensus is
N/A
The current consensus among 0 investment analysts is to n/a stock in Carr's Group. This N/A consensus rating has held steady for over two years.
Carr's Group plc engages in the agriculture and engineering businesses in the United Kingdom and internationally. The company's Speciality Agriculture segment manufactures and supplies supplementation products for livestock. It offers feed blocks under the Crystalyx, Horslyx, and SmartLic brands; boluses under the Tracesure brand; and protein products under the AminoMax brand. Its Engineering segment designs and manufactures equipment for the nuclear, petrochemical, naval defence, pharmaceutical, process, renewable energy industries, and oil and gas industries; and offers remote handling equipment, life-of-plant extension technologies, radiation protection, decontamination services, robotics, specialist fabrication, and precision machining. This segment also provides value added solutions to the nuclear defence, nuclear decommissioning, nuclear power generation, and other regulated markets. In addition, it engages in the financial and property holding activities. The company was formerly known as Carr's Milling Industries PLC and changed its name to Carr's Group plc in April 2015. Carr's Group plc was founded in 1831 and is based in Carlisle, the United Kingdom.
Read More
